Rock Springs Capital Management LP Amryt Pharma PLC Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.8 - $8.01 $88,400 - $104,130
13,000 Added 0.99%
1,325,625 $9.17 Million
Q2 2022

Aug 15, 2022
BUY
$6.85 - $8.87 $46,580 - $60,315
6,800 Added 0.52%
1,312,625 $9.18 Million
Q4 2021

Feb 14, 2022
BUY
$9.44 - $12.24 $100,064 - $129,744
10,600 Added 0.82%
1,305,825 $14.1 Million
Q3 2021

Nov 15, 2021
BUY
$9.63 - $12.47 $12.5 Million - $16.2 Million
1,295,225 New
1,295,225 $15.6 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email